Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Lung Neoplasms 9Lymphoma, Large-Cell, Anaplastic 4Carcinoma 4Carcinoma, Squamous Cell 2Carcinoma, Large Cell 2Brain Neoplasms 2Adenocarcinoma 2ALK-positive Advanced NSCLC 2Sexual Dysfunction, Physiological 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms 1Neoplasm Metastasis 1NSCLC 1Meningioma 1Granuloma, Plasma Cell 1Gastrointestinal Neoplasms 1Eunuchism 1Erectile Dysfunction 1Ependymoma 1Disease Progression 1Carcinoma, Pancreatic Ductal 1Breast Neoplasms 1ALK-positive NSCLC 1ALK+ Advanced NSCLC 1

Interventions

Crizotinib 4ceritinib 3pazopanib 2Ifosfamide 2Doxorubicin 2selinexor 1repotrectinib 1brigatinib 1Suspensions 1Radiotherapy 1Radiation 1Proton Therapy 1Capsules 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Granuloma, Plasma Cell × brigatinib × Clear all
NCT04925609 2025-12-05

Briga-PED

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Recruiting
65 enrolled
LymphoidPlasma cell

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡